Targeted drug delivery strategies for precision medicines. Academic Article uri icon

Overview

abstract

  • Progress in the field of precision medicine has changed the landscape of cancer therapy. Precision medicine is propelled by technologies that enable molecular profiling, genomic analysis, and optimized drug design to tailor treatments for individual patients. Although precision medicines have resulted in some clinical successes, the use of many potential therapeutics has been hindered by pharmacological issues, including toxicities and drug resistance. Drug delivery materials and approaches have now advanced to a point where they can enable the modulation of a drug's pharmacological parameters without compromising the desired effect on molecular targets. Specifically, they can modulate a drug's pharmacokinetics, stability, absorption, and exposure to tumours and healthy tissues, and facilitate the administration of synergistic drug combinations. This Review highlights recent progress in precision therapeutics and drug delivery, and identifies opportunities for strategies to improve the therapeutic index of cancer drugs, and consequently, clinical outcomes.

publication date

  • February 2, 2021

Identity

PubMed Central ID

  • PMC8691416

Scopus Document Identifier

  • 85100295040

Digital Object Identifier (DOI)

  • 10.1038/s41578-020-00269-6

PubMed ID

  • 34950512

Additional Document Info

volume

  • 6

issue

  • 4